CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy
Inkeun Park, Seung Joon Choi, Young Saing Kim, Hee Kyung Ahn, Junshik Hong, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Jae Hoon Lee, Yong Ju Shin, Dong Bok Shin
Cancer Research and Treatment. 2016;48(4):1264-1273.   Published online 2016 March 23    DOI: https://doi.org/10.4143/crt.2015.250

Excel Download

Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy
Cancer Research and Treatment. 2016;48(4):1264-1273   Crossref logo
Link1 Link2 Link3

Prognostic impact of progression type by RECIST criteria in patients with metastatic pancreatic cancer who received first-line gemcitabine-based chemotherapy
Annals of Oncology. 2018;29:ix64   Crossref logo
Link1 Link2 Link3

Prognostic Factors in Patients with Metastatic Pancreatic Adenocarcinoma Receiving Systemic Chemotherapy
Oncology. 2000;59(4):296-301   Crossref logo
Link1 Link2

Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: Proposal for a new prognostic model
Gynecologic Oncology. 2008;108(1):130-135   Crossref logo
Link1 Link2

The impact of neutrophil to lymphocyte ratio as a prognostic factor in Japanese patients with unresectable pancreatic cancer treated with gemcitabine-based chemotherapy
HPB. 2019;21:S419   Crossref logo
Link1 Link2

Prognostic Factors in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine Chemotherapy: Clinical Characteristics of Long-Term Survivors
Annals of Oncology. 2014;25:ii46   Crossref logo
Link1 Link2 Link3

Tu1537: PERI-TREATMENT ANTIBIOTICS IMPROVE SURVIVAL OF PATIENTS WITH METASTATIC PANCREATIC ADENOCARCINOMA TREATED WITH FIRST-LINE GEMCITABINE-BASED CHEMOTHERAPY: A SEER-MEDICARE STUDY
Gastroenterology. 2022;162(7):S-1001-S-1002   Crossref logo
Link1 Link2

Prognostic Factors in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine Chemotherapy: Clinical Characteristics of Long-term Survivors
The Korean Journal of Gastroenterology. 2014;64(6):356   Crossref logo
Link1 Link2 Link3

782 IDENTIFICATION OF PROGNOSTIC PREDICTORS IN JAPANESE MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO WERE TREATED WITH DOCETAXEL-BASED CHEMOTHERAPY
Journal of Urology. 2013;189(4S):   Crossref logo
Link1 Link2 Link3

Prognostic significance of nutritional and inflammatory markers in patients with unresectable/metastatic (UR-M) pancreatic ductal adenocarcinoma treated with chemotherapy
HPB. 2019;21:S418   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.